美国证交会公告 - Ascentage Pharma Group International

Detailed SEC Filings
Filing Date	Form	Description	Filing Group	View
09-29-26	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	View HTML 0001213900-26-104196.pdf 0001213900-26-104196.rtf 0001213900-26-104196.xls
09-17-26	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	View HTML 0001213900-26-100763.pdf 0001213900-26-100763.rtf 0001213900-26-100763.xls
08-20-26	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	View HTML 0001213900-26-091901.pdf 0001213900-26-091901.rtf 0001213900-26-091901.xls
08-13-26	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	View HTML 0001213900-26-088773.pdf 0001213900-26-088773.rtf 0001213900-26-088773.xls
08-05-26	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	View HTML 0001213900-26-085424.pdf 0001213900-26-085424.rtf 0001213900-26-085424.xls
08-03-26	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	View HTML 0001213900-26-084247.pdf 0001213900-26-084247.rtf 0001213900-26-084247.xls
07-27-26	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	View HTML 0001213900-26-081816.pdf 0001213900-26-081816.rtf 0001213900-26-081816.xls
07-20-26	F-3ASR	F-3ASR	Other	View HTML 0001213900-26-079362.pdf 0001213900-26-079362.rtf 0001213900-26-079362.xls XML - XBRL INSTANCE DOCUMENT
07-20-26	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	View HTML 0001213900-26-079420.pdf 0001213900-26-079420.rtf 0001213900-26-079420.xls
07-13-26	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	View HTML 0001213900-26-077607.pdf 0001213900-26-077607.rtf 0001213900-26-077607.xls